Hypogammaglobulinemia in systemic lupus erythematosus (SLE) and increased BAFF serum levels in cancer chemoimmunotherapy are thought to be a consequence of cyclophosphamide treatment [65]. The gene discussed is TNFSF13B; the disease is systemic lupus erythematosus.